Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells

被引：8
|
作者：
De Martino, Maria Cristina [1 ]
van Koetsveld, Peter M. [1 ]
Feelders, Richard A. [1 ]
Lamberts, Steven W. J. [1 ]
de Herder, Wouter W. [1 ]
Colao, Annamaria [2 ]
Pivonello, Rosario [2 ]
Hofland, Leo J. [1 ]
机构：
[1] Erasmus MC, Div Endocrinol, Dept Internal Med, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands
[2] Univ Naples Federico II, Dipartimento Med Clin & Chirurg, Sez Endocrinol, Via S Pansini 5, I-80131 Naples, Italy
来源：
ENDOCRINE | 2016年 / 52卷 / 03期
关键词：
MAMMALIAN TARGET; MTOR PATHWAY; INHIBITOR; CANCER; TEMSIROLIMUS; MANAGEMENT; EVEROLIMUS; TUMORS;
D O I：
10.1007/s12020-015-0818-0
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：664 / 667
页数：4
相关论文
共 50 条
  • [1] Effects of combination treatment with sirolimus and mitotane on growth of human adrenocortical carcinoma cells
    Maria Cristina De Martino
    Peter M. van Koetsveld
    Richard A. Feelders
    Steven W. J. Lamberts
    Wouter W. de Herder
    Annamaria Colao
    Rosario Pivonello
    Leo J. Hofland
    Endocrine, 2016, 52 : 664 - 667
  • [2] The Efficacy of Mitotane in Human Primary Adrenocortical Carcinoma Cultures
    van Koetsveld, Peter M.
    Creemers, Sara G.
    Dogan, Fadime
    Franssen, Gaston J. H.
    de Herder, Wouter W.
    Feelders, Richard A.
    Hofland, Leo J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 105 (02) : 407 - 417
  • [3] Practical treatment using mitotane for adrenocortical carcinoma
    Terzolo, Massimo
    Zaggia, Barbara
    Allasino, Barbara
    De Francia, Silvia
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2014, 21 (03) : 159 - 165
  • [4] New perspectives for mitotane treatment of adrenocortical carcinoma
    Puglisi, S.
    Calabrese, A.
    Basile, V
    Pia, A.
    Reimondo, G.
    Perotti, P.
    Terzolo, M.
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2020, 34 (03)
  • [5] Interferon-β is a potent inhibitor of cell growth and cortisol production in vitro and sensitizes human adrenocortical carcinoma cells to mitotane
    van Koetsveld, Peter M. t
    Vitale, Giovanni
    Feelders, Richard A.
    Waaijers, Marlijn
    Sprij-Mooij, Diana M.
    de Krijger, Ronald R.
    Speel, Ernst-Jan M.
    Hofland, Johannes
    Lamberts, Steven W. J.
    de Herder, Wouter W.
    Hofland, Leo J.
    ENDOCRINE-RELATED CANCER, 2013, 20 (03) : 443 - 454
  • [6] Combination of Mitotane and Locoregional Treatments in Low-volume Metastatic Adrenocortical Carcinoma
    Boileve, Alice
    Mathy, Elise
    Roux, Charles
    Faron, Matthieu
    Hadoux, Julien
    Tselikas, Lambros
    Al Ghuzlan, Abir
    Hescot, Segolene
    Leboulleux, Sophie
    de Baere, Thierry
    Lamartina, Livia
    Deschamps, Frederic
    Baudin, Eric
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2021, 106 (11) : E4698 - E4707
  • [7] Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma
    Allegra, Sarah
    Puglisi, Soraya
    Brescia, Irene
    Chiara, Francesco
    Basile, Vittoria
    Calabrese, Anna
    Reimondo, Giuseppe
    De Francia, Silvia
    LIFE-BASEL, 2021, 11 (03):
  • [8] Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma
    Reimondo, Giuseppe
    Puglisi, Soraya
    Zaggia, Barbara
    Basile, Vittoria
    Saba, Laura
    Perotti, Paola
    De Francia, Silvia
    Volante, Marco
    Zatelli, Maria Chiara
    Cannavo, Salvatore
    Terzolo, Massimo
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2017, 177 (04) : 361 - 367
  • [9] Cytotoxic activity of gemcitabine, alone or in combination with mitotane, in adrenocortical carcinoma cell lines
    Germano, Antonina
    Rapa, Ida
    Volante, Marco
    Lo Buono, Nicola
    Carturan, Sonia
    Berruti, Alfredo
    Terzolo, Massimo
    Papotti, Mauro
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2014, 382 (01) : 1 - 7
  • [10] Efficacy and safety of mitotane in the treatment of adrenocortical carcinoma: A retrospective study in 34 Belgian patients
    Maiter, Dominique
    Bex, Marie
    Vroonen, Laurent
    T'Sjoen, Guy
    Gil, Thierry
    Banh, Camille
    Chadarevian, Rita
    ANNALES D ENDOCRINOLOGIE, 2016, 77 (05) : 578 - 585
12345